Australia's most trusted source of pharma news
Tuesday, 23 April 2019
Lost Your Access?
Teva CEO pockets biggest pay
Shoots to top of global compensation scale.
Another setback for Lemtrada
TGA considers next steps after Europe restricts use.
Threat to 'deck' manager true
Unfair dismissal case against Allergan and its MD sent packing.
Sanofi's Quasimodo moment
Donates millions to Notre-Dame rebuild.
Mundi gives kids Easter treat
Special outing for children from Barnardo's centre.
GSK bullying claim hits Banks
Pharma named in damaging election-related allegations.
PBS 'crumbling', 'being destroyed'
Election combatants tout PBS support but reality is different.
Merck moves to Pill Hill
Over 120 Sydney staff to unite in Macquarie Park office.
Ex-pharma man in line for seat
Labor candidate has long lead on Liberal opponent.
Mabthera biosim to launch
Federal Court settlement opens $106m market.
Call for new therapeutic groups
$400m+ in potential savings awaiting election winner.
DHL was denied CSO cash
Confirms it was excluded, 'regrets' DOH decision.
Thrust, parry in cancer vote duel
Promise v promise as Hunt reacts to Labor's
Right to Trial
API kicks government over CSO
Welcomes new deeds but says more CSO money needed.
Aust first for long-awaited gel
Innovative locally-developed therapy rolls out in pharmacies.
Teva adds MS option
New pen presentation approved.
Top of the Hill
Reform rolls on despite election
Industry may be more affected by change already on foot.
Events & Conferences
© 2003 - 2019 Lush Media
Pharma in Focus
Jolly Good Design